---
title: "Vabysmo (faricimab-svoa), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Vabysmo (faricimab-svoa) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing, Administration, and Preparation. Questions: What is the maximum recommended dose of Vabysmo? How is a Vabysmo intravitreal injection given? How is Vabysmo given when both eyes need treatment? What needle is used for Vabysmo injections? 1 further question follow. 5 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/vabysmo/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Vabysmo (faricimab-svoa), all indications: Dosing and administration questions

Manufacturer: Genentech, Inc.  
Prescribing information: [Vabysmo](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf)  
Indication pages: [Neovascular age-related macular degeneration](https://www.evicenter.com/medical-information/vabysmo--neovascular-age-related-macular-degeneration)

## Dosing

<a id="vabysmo-max-dose"></a>

### What is the maximum recommended dose of Vabysmo?

> “Although additional efficacy was not demonstrated in most patients when VABYSMO was 
> dosed every 4 weeks compared to every 8 weeks, some patients may need every 4 week 
> (monthly) dosing after the first 4 doses.”

Source: [VABYSMO: Prescribing information, page 2, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=2)

> “Serum exposure (Cmax) in pregnant monkeys at the low dose of 1 mg/kg 
> was 158 times the human exposure at the maximum recommended intravitreal dose of 6 mg once 
> every 4 weeks.”

Source: [VABYSMO: Prescribing information, page 13, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=13)

Note: The first passage is from the nAMD dosing section of the label (section 2.2). The second is from the label's animal reproduction data (section 8.1); its 158-times figure compares exposure in pregnant monkeys with human exposure, and the passage names 6 mg once every 4 weeks as the maximum recommended intravitreal dose.

## Administration

<a id="vabysmo-injection-procedure"></a>

### How is a Vabysmo intravitreal injection given?

> “For intravitreal injection. VABYSMO must be administered by a qualified physician.”

Source: [VABYSMO: Prescribing information, page 2, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=2)

> “The intravitreal injection procedure must be carried out under aseptic conditions, which 
> includes the use of surgical hand disinfection, sterile gloves, a sterile drape and a sterile 
> eyelid speculum (or equivalent), and the availability of sterile paracentesis equipment (if 
> required). Adequate anesthesia and a broad-spectrum microbicide should be administered 
> prior to the injection.”

Source: [VABYSMO: Prescribing information, page 9, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=9)

> “Inject slowly until the rubber stopper reaches the end of the syringe to deliver the volume of 
> 0.05 mL.”

Source: [VABYSMO: Prescribing information, page 9, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=9)

<a id="vabysmo-both-eyes"></a>

### How is Vabysmo given when both eyes need treatment?

> “Each syringe should only be used for the treatment of a single eye. If the contralateral eye 
> requires treatment, a new syringe should be used and the sterile field, syringe, gloves, drapes, 
> eyelid speculum, filter, and injection needles should be changed before VABYSMO is 
> administered to the other eye.”

Source: [VABYSMO: Prescribing information, page 10, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=10)

## Preparation

<a id="vabysmo-needle"></a>

### What needle is used for Vabysmo injections?

> “A sterile injection filter needle (30-gauge x ½ inch, Extra Thin Wall) with 
> an integrated filter in the hub. The injection filter needle is for single use 
> only.”

Source: [VABYSMO: Prescribing information, page 3, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=3)

> “Only use the provided injection filter needle for the administration.”

Source: [VABYSMO: Prescribing information, page 3, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=3)

> “• One sterile injection needle 30-gauge x ½ inch (not included) 
> Note that a 30-gauge injection needle is recommended to avoid 
> increased injection forces that could be experienced with smaller 
> diameter needles.”

Source: [VABYSMO: Prescribing information, page 7, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=7)

Note: The first two passages are from the prefilled syringe preparation instructions (section 2.5 of the label); the third is from the vial preparation instructions (section 2.6).

<a id="vabysmo-preparation"></a>

### How should Vabysmo be prepared before injection?

> “Allow VABYSMO to reach room temperature, 20°C to 25°C (68°F to 
> 77°F) before proceeding with the administration.”

Source: [VABYSMO: Prescribing information, page 3, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=3)

> “Do not use if particulates, cloudiness, or discoloration are visible. 
> VABYSMO is a clear to opalescent and colorless to brownish-yellow liquid 
> solution.”

Source: [VABYSMO: Prescribing information, page 3, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=3)

> “Ensure that the injection is given immediately after preparation of the dose.”

Source: [VABYSMO: Prescribing information, page 5, captured 2026-11-13](https://www.gene.com/download/pdf/vabysmo_prescribing.pdf#page=5)

## Related pages
- [Medical information: Vabysmo (faricimab-svoa): All indications](https://www.evicenter.com/medical-information/vabysmo)
- [Indication](https://www.evicenter.com/medical-information/vabysmo/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/vabysmo/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/vabysmo/safety)
- [Specific populations](https://www.evicenter.com/medical-information/vabysmo/specific-populations)
- [Storage and supply](https://www.evicenter.com/medical-information/vabysmo/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/vabysmo/access-and-coverage)
